Interobserver agreement in the histopathological classification of desmoplastic melanomas

Cecilia Lezcano*, Marianne Berwick, Li Luo, Raymond Barnhill, Lyn M. Duncan, Pedram Gerami, Lori Lowe, Jane L. Messina, Richard A. Scolyer, Benjamin Wood, Iwei Yeh, Artur Zembowicz, Klaus J. Busam

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Desmoplastic melanoma is a subtype of melanoma characterised by amelanotic fusiform melanocytes dispersed in a collagenous stroma. Cell-poor and fibrous stroma-rich ‘pure’ variants have been distinguished from ‘mixed’ variants with areas of higher cell density and/or less desmoplastic stroma. This distinction is relevant because patients whose tumours display a pure phenotype have a lower risk for regional lymph node metastasis and distant recurrence. However, little is known about interobserver agreement among pathologists in the subclassification of desmoplastic melanoma. To address this issue, we conducted a study in which eleven dermatopathologists independently evaluated whole slide scanned images of excisions from 30 desmoplastic melanomas. The participating pathologists were asked to classify the tumours as pure or mixed. They were also asked to record the presence or absence of neurotropism and angiotropism. We found substantial interobserver agreement between the 11 dermatopathologists in the classification of tumours as pure versus mixed desmoplastic melanoma (kappa=0.64; p<0.0001). There was fair agreement between the 11 dermatopathologists in the evaluation of presence versus absence of neurotropism (kappa=0.26; p<0.0001), and slight agreement in the assessment of angiotropism (kappa=0.13; p<0.0001). The level of concordance in the subclassification of desmoplastic melanomas is encouraging for the acceptance of this prognostic parameter in the real-world practice of melanoma pathology.

Original languageEnglish (US)
Pages (from-to)223-226
Number of pages4
JournalPathology
Volume55
Issue number2
DOIs
StatePublished - Mar 2023

Funding

Research reported in this publication was supported in part by the Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute under award number P30CA008748. RAS is supported by a National Health and Medical Research Council of Australia (NHMRC) Practitioner Fellowship (APP1141295). RAS has received fees for professional services from MetaOptima Technology Inc, F. Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, Merck Sharp & Dohme, NeraCare, AMGEN Inc, Bristol-Myers Squibb, Myriad Genetics, GlaxoSmithKline. The remaining authors have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Keywords

  • Desmoplastic
  • angiotropism
  • melanoma
  • mixed
  • neurotropism
  • pure

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Interobserver agreement in the histopathological classification of desmoplastic melanomas'. Together they form a unique fingerprint.

Cite this